Choroidal vascularity index as an activity criterion and a treatment response measure in chronic central serous chorioretinopathy
Ophthalmic and Physiological Optics · 2023-09 · 43 (5) · 1203-1210
DOI: 10.1111/opo.13187 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmic and Physiological Optics, online erschienen am 15.06.2023. Verfasst von Mehmet Orkun Sevik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Marmara University School of Medicine, Istanbul, Turkey. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy, Phototherapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
This study aimed to evaluate the choroidal vascularity index (CVI) as an activity criterion in chronic central serous chorioretinopathy (CSC) and as a measure of treatment response after full‐dose‐full‐fluence photodynamic therapy (fd‐ff‐PDT).
Methods
This fellow‐eye‐controlled, retrospective cohort study included 23 patients with unilateral chronic CSC treated with fd‐ff‐PDT (6 mg/m 2 ; 50 μcm 2 ; 83 s). Subfoveal choroidal thickness (SFCT, μm) and CVI (%) of the affected and fellow eyes at baseline as well as at 1, 3 and 6 months after fd‐ff‐PDT were compared.
Results
The patients' mean age was 43.4 ± 7.3 years, and 18 (78.3%) were male. CVI was comparable between the affected and fellow eyes at baseline (66.09 ± 1.56 vs. 65.84 ± 1.57, p = 0.59). However, it became significantly lower in the affected eyes 1 (64.45 ± 1.68 vs. 65.87 ± 1.19, p = 0.002), 3 (64.21 ± 2.08 vs. 65.71 ± 1.59, p = 0.009) and 6 (64.47 ± 2.19 vs. 65.62 ± 1.52, p = 0.045) months after fd‐ff‐PDT. The mean SFCT and the mean CVI were significantly decreased in the affected eyes at all follow‐up visits compared with baseline after fd‐ff‐PDT ( p < 0.001).
Conclusion
At baseline, CVI was comparable between affected and fellow eyes. Therefore, its use as an activity criterion in chronic CSC patients is questionable. However, it was significantly decreased in fd‐ff‐PDT‐treated eyes, supporting its role as a measure of treatment response in chronic CSC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Marmara University School of Medicine, Istanbul, Turkey.
ORCID-Profile: Mehmet Orkun Sevik, Aslan Aykut, Furkan Çam, Volkan Dericioğlu, Özlem Şahin
Zitieren
APA
Sevik, M. O., Aykut, A., Çam, F., Dericioğlu, V., & Şahin, Ö. (2023). Choroidal vascularity index as an activity criterion and a treatment response measure in chronic central serous chorioretinopathy. Ophthalmic and Physiological Optics, 43(5), 1203-1210. https://doi.org/10.1111/opo.13187
Vancouver
Sevik MO, Aykut A, Çam F, Dericioğlu V, Şahin Ö. Choroidal vascularity index as an activity criterion and a treatment response measure in chronic central serous chorioretinopathy. Ophthalmic and Physiological Optics. 2023;43(5):1203-1210. doi:10.1111/opo.13187
BibTeX
@article{Sevik2023,
author = {Sevik, Mehmet Orkun and Aykut, Aslan and Çam, Furkan and Dericioğlu, Volkan and Şahin, Özlem},
title = {Choroidal vascularity index as an activity criterion and a treatment response measure in chronic central serous chorioretinopathy},
journal = {Ophthalmic and Physiological Optics},
year = {2023},
volume = {43},
number = {5},
pages = {1203--1210},
doi = {10.1111/opo.13187}
}
EUVIMED